Corporate Management Tips From Three Former/Outgoing Device CEOs
This article was originally published in The Gray Sheet
Executive Summary
John Brown of Stryker, Jack Wareham of Beckman Coulter and Ron Dollens of Guidant, who have a cumulative 50 years of experience spearheading large corporations, each began in pharma. After working at Squibb Corp., Brown served as CEO of Stryker for 28 years, retiring in January; he remains as chairman. Wareham worked at SmithKline before joining Beckman Instruments in 1984 and becoming president in 1993 and CEO in 1998. He retired as CEO in January and will step down as chairman in April. Dollens came up through Eli Lilly and has served as CEO of Guidant since 1995. He plans to retire once Guidant merges with Johnson & Johnson. Their comments derive from a March 4 Q&A session at AdvaMed's annual meeting in Dana Point, Calif.